RGNX – REGENXBIO Inc.
REGENXBIO Inc.RGNX
$8.19Name : REGENXBIO Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $412,683,424.00
EPSttm : -3.09
REGENXBIO Inc.
$8.19
3.76%$0.32Float Short %
13.53
Margin Of Safety %
Put/Call OI Ratio
0.54
EPS Next Q Diff
0.96
EPS Last/This Y
4.82
EPS This/Next Y
-1.75
Price
8.19
Target Price
32.85
Analyst Recom
1.38
Performance Q
-16.68
Relative Volume
0.54
Beta
1.11
Ticker: RGNX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-04 | RGNX | 8.74 | 0.57 | 0.38 | 4395 |
| 2025-07-07 | RGNX | 8.43 | 0.57 | 0.13 | 4410 |
| 2025-07-08 | RGNX | 8.74 | 0.57 | 0.12 | 4403 |
| 2025-07-09 | RGNX | 9.16 | 0.57 | 0.00 | 4401 |
| 2025-07-10 | RGNX | 9.08 | 0.57 | 0.00 | 4404 |
| 2025-07-11 | RGNX | 8.68 | 0.56 | 0.00 | 4454 |
| 2025-07-14 | RGNX | 8.72 | 0.56 | 6.00 | 4448 |
| 2025-07-15 | RGNX | 8.23 | 0.55 | 0.10 | 4442 |
| 2025-07-16 | RGNX | 8.5 | 0.54 | 0.00 | 4518 |
| 2025-07-17 | RGNX | 8.67 | 0.54 | 0.38 | 4526 |
| 2025-07-18 | RGNX | 8.18 | 0.54 | 0.07 | 4508 |
| 2025-07-21 | RGNX | 8.49 | 0.56 | 0.63 | 3521 |
| 2025-07-22 | RGNX | 8.57 | 0.56 | 1.76 | 3558 |
| 2025-07-23 | RGNX | 9.09 | 0.57 | 0.04 | 3565 |
| 2025-07-24 | RGNX | 9.13 | 0.56 | 0.10 | 3590 |
| 2025-07-25 | RGNX | 8.96 | 0.56 | 0.00 | 3612 |
| 2025-07-28 | RGNX | 8.79 | 0.55 | 0.00 | 3637 |
| 2025-07-29 | RGNX | 8.43 | 0.55 | 0.69 | 3655 |
| 2025-07-30 | RGNX | 8.75 | 0.55 | 0.07 | 3679 |
| 2025-07-31 | RGNX | 8.5 | 0.54 | 0.00 | 3693 |
| 2025-08-01 | RGNX | 8.18 | 0.54 | 6.60 | 3705 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-04 | RGNX | 8.74 | -0.4 | 223.9 | 0.23 |
| 2025-07-07 | RGNX | 8.43 | -0.4 | 216.7 | 0.23 |
| 2025-07-08 | RGNX | 8.74 | -0.4 | 227.2 | 0.23 |
| 2025-07-09 | RGNX | 9.17 | -0.4 | 229.0 | 0.23 |
| 2025-07-10 | RGNX | 9.06 | -0.4 | 220.3 | 0.23 |
| 2025-07-11 | RGNX | 8.68 | -0.4 | 214.3 | 0.23 |
| 2025-07-14 | RGNX | 8.70 | -0.4 | 222.2 | 0.23 |
| 2025-07-15 | RGNX | 8.24 | -0.4 | 214.1 | 0.23 |
| 2025-07-16 | RGNX | 8.51 | -0.4 | 226.8 | 0.23 |
| 2025-07-17 | RGNX | 8.69 | -0.4 | 225.2 | 0.23 |
| 2025-07-18 | RGNX | 8.16 | -0.4 | 212.8 | 0.23 |
| 2025-07-21 | RGNX | 8.49 | -0.4 | 228.2 | 0.23 |
| 2025-07-22 | RGNX | 8.59 | -0.4 | 223.5 | 0.23 |
| 2025-07-23 | RGNX | 9.09 | -0.4 | 230.7 | 0.23 |
| 2025-07-24 | RGNX | 9.13 | -0.4 | 222.6 | 0.23 |
| 2025-07-25 | RGNX | 8.96 | -0.4 | 219.4 | 0.23 |
| 2025-07-28 | RGNX | 8.76 | -0.4 | 218.6 | 0.23 |
| 2025-07-29 | RGNX | 8.41 | -0.4 | 215.4 | 0.23 |
| 2025-07-30 | RGNX | 8.75 | -0.4 | 227.6 | 0.23 |
| 2025-07-31 | RGNX | 8.51 | -0.4 | 217.7 | 0.23 |
| 2025-08-01 | RGNX | 8.19 | -0.4 | 216.1 | 0.23 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-04 | RGNX | -0.43 | 2.33 | 12.07 |
| 2025-07-07 | RGNX | -0.43 | 2.35 | 12.07 |
| 2025-07-08 | RGNX | -0.43 | 2.35 | 12.07 |
| 2025-07-09 | RGNX | -0.43 | 2.35 | 12.07 |
| 2025-07-10 | RGNX | -0.43 | 2.35 | 12.07 |
| 2025-07-11 | RGNX | -0.43 | 2.35 | 13.43 |
| 2025-07-14 | RGNX | -0.43 | 2.49 | 13.43 |
| 2025-07-15 | RGNX | -0.43 | 2.49 | 13.43 |
| 2025-07-16 | RGNX | -0.43 | 2.49 | 13.43 |
| 2025-07-17 | RGNX | -0.43 | 2.49 | 13.43 |
| 2025-07-18 | RGNX | -0.43 | 2.49 | 13.43 |
| 2025-07-21 | RGNX | -0.43 | -8.77 | 13.43 |
| 2025-07-22 | RGNX | -0.43 | -8.77 | 13.43 |
| 2025-07-23 | RGNX | -0.43 | -8.77 | 13.43 |
| 2025-07-24 | RGNX | -0.43 | -8.77 | 13.43 |
| 2025-07-25 | RGNX | -0.43 | -8.77 | 13.53 |
| 2025-07-28 | RGNX | -0.43 | -1.53 | 13.53 |
| 2025-07-29 | RGNX | -0.43 | -1.53 | 13.53 |
| 2025-07-30 | RGNX | -0.43 | -1.53 | 13.53 |
| 2025-07-31 | RGNX | -0.43 | -1.53 | 13.53 |
| 2025-08-01 | RGNX | -0.43 | -1.53 | 13.53 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.12
Avg. EPS Est. Current Quarter
-1.05
Avg. EPS Est. Next Quarter
1.08
Insider Transactions
-0.43
Institutional Transactions
-1.53
Beta
1.11
Average Sales Estimate Current Quarter
40
Average Sales Estimate Next Quarter
110
Fair Value
Quality Score
42
Growth Score
31
Sentiment Score
26
Actual DrawDown %
83.7
Max Drawdown 5-Year %
-89.4
Target Price
32.85
P/E
Forward P/E
PEG
P/S
2.63
P/B
1.5
P/Free Cash Flow
EPS
-3.14
Average EPS Est. Cur. Y
0.23
EPS Next Y. (Est.)
-1.52
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-100.62
Relative Volume
0.54
Return on Equity vs Sector %
-81.2
Return on Equity vs Industry %
-62.6
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
216.1
REGENXBIO Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 353
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's products in pipeline includes ABBV-RGX-314 for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other chronic retinal diseases; and RGX-202, which is in Phase III clinical trial for the treatment of Duchenne muscular dystrophy, as well as RGX-121 for the treatment of mucopolysaccharidosis type II. It also develops RGX-111 for the treatment of mucopolysaccharidosis type I, RGX-181 for the treatment of late-infantile neuronal ceroid lipofuscinosis type 2, and RGX-381 for the treatment of the ocular manifestations of CLN2 disease. In addition, the company licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies. Further, it has a collaboration and license agreement with AbbVie Global Enterprises Ltd. to develop ABBV-RGX-314 outside the United States. REGENXBIO Inc. was incorporated in 2008 and is headquartered in Rockville, Maryland.
stock quote shares RGNX – REGENXBIO Inc. Stock Price stock today
news today RGNX – REGENXBIO Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch RGNX – REGENXBIO Inc. yahoo finance google finance
stock history RGNX – REGENXBIO Inc. invest stock market
stock prices RGNX premarket after hours
ticker RGNX fair value insiders trading